Tomas Olsson Selected Research

EBV-encoded nuclear antigen 1

12/2021	Low sun exposure acts synergistically with high Epstein-Barr nuclear antigen 1 (EBNA-1) antibody levels in multiple sclerosis etiology.
10/2021	Factors affecting the risk of relapsing-onset and progressive-onset multiple sclerosis.
1/2021	DRB1-environment interactions in multiple sclerosis etiology: results from two Swedish case-control studies.
1/2021	Overweight/obesity in young adulthood interacts with aspects of EBV infection in MS etiology.
1/2020	Smoking and Epstein-Barr virus infection in multiple sclerosis development.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomas Olsson Research Topics

Disease

127	Multiple Sclerosis 11/2022 - 03/2002
30	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2021 - 07/2002
20	Inflammation (Inflammations) 01/2021 - 03/2003
19	Autoimmune Diseases (Autoimmune Disease) 09/2021 - 09/2003
16	Neuroinflammatory Diseases 12/2020 - 12/2002
13	Relapsing-Remitting Multiple Sclerosis 01/2022 - 02/2003
10	Infections 07/2022 - 09/2009
10	Epstein-Barr Virus Infections 12/2021 - 09/2012
10	Demyelinating Diseases (Demyelinating Disease) 01/2020 - 07/2002
8	Progressive Multifocal Leukoencephalopathy 05/2021 - 09/2009
7	Obesity 10/2021 - 03/2014
6	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022 - 05/2005
6	Disease Progression 10/2015 - 09/2003
5	Infectious Mononucleosis (Glandular Fever) 01/2021 - 09/2014
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020 - 01/2015
5	Postpoliomyelitis Syndrome (Post-Polio Syndrome) 07/2012 - 12/2002
4	Genetic Risk Score 11/2020 - 10/2016
4	Rheumatoid Arthritis 01/2020 - 05/2005
4	Encephalomyelitis (Myeloencephalitis) 04/2009 - 07/2003
3	Congenital heart block 01/2022 - 01/2005
3	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2016
3	Pediatric Obesity 01/2021 - 01/2016
3	Dementia (Dementias) 01/2021 - 01/2019
3	Cognitive Dysfunction 01/2021 - 11/2019
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 05/2011
3	Neoplasms (Cancer) 01/2020 - 09/2010
3	Human Influenza (Influenza) 10/2017 - 05/2014
3	Narcolepsy 10/2017 - 05/2014
3	Central Nervous System Diseases (CNS Diseases) 12/2016 - 10/2013
3	Nervous System Diseases (Neurological Disorders) 05/2014 - 09/2010
3	Poliomyelitis (Polio) 03/2006 - 12/2002
2	Atrioventricular Block 01/2022 - 01/2005
2	Prostatic Neoplasms (Prostate Cancer) 04/2021 - 05/2012
2	Vitamin D Deficiency 04/2020 - 12/2010

Drug/Important Bio-Agent (IBA)

22	Myelin-Oligodendrocyte GlycoproteinIBA 01/2019 - 07/2002
20	Biomarkers (Surrogate Marker)IBA 04/2021 - 01/2009
18	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2003
17	AntibodiesIBA 01/2021 - 10/2007
16	AutoantibodiesIBA 01/2022 - 09/2003
16	Vitamin D FDA LinkGeneric 12/2021 - 09/2010
15	Natalizumab (Tysabri)FDA Link 05/2021 - 09/2009
12	HLA-DRB1 Chains (HLA DRB1)IBA 10/2021 - 03/2014
11	AntigensIBA 01/2021 - 06/2008
11	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 03/2011
11	Immunoglobulin G (IgG)IBA 01/2021 - 06/2012
9	CytokinesIBA 01/2019 - 11/2002
8	Oligoclonal BandsIBA 12/2016 - 01/2013
7	Peptides (Polypeptides)IBA 01/2017 - 02/2003
6	Messenger RNA (mRNA)IBA 09/2010 - 12/2002
5	Pharmaceutical PreparationsIBA 11/2022 - 03/2013
5	AutoantigensIBA 04/2022 - 10/2003
5	EBV-encoded nuclear antigen 1IBA 12/2021 - 01/2020
5	HLA-A Antigens (HLA-A)IBA 11/2020 - 09/2012
5	LigandsIBA 08/2016 - 09/2007
5	EpitopesIBA 10/2015 - 01/2005
4	Rituximab (Mabthera)FDA Link 11/2022 - 04/2011
4	Myelin Basic ProteinIBA 01/2021 - 02/2003
4	Fingolimod Hydrochloride (FTY720)FDA Link 01/2020 - 12/2014
4	SolventsIBA 01/2019 - 01/2016
4	Complement System Proteins (Complement)IBA 01/2015 - 10/2007
4	Intravenous Immunoglobulins (IVIG)FDA Link 07/2012 - 05/2004
3	HLA-DR15 antigenIBA 01/2021 - 01/2018
3	ORALIT (ORS)IBA 01/2021 - 01/2020
3	VaccinesIBA 01/2021 - 01/2016
3	Blood Proteins (Serum Proteins)IBA 01/2020 - 12/2011
3	Interleukin-22 (IL-22)IBA 01/2019 - 12/2010
3	LipidsIBA 11/2017 - 06/2012
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 02/2003
3	ChemokinesIBA 08/2016 - 10/2003
3	OsteopontinIBA 08/2016 - 01/2011
3	Interleukin-7 (Interleukin 7)IBA 11/2014 - 09/2007
3	Monoclonal AntibodiesIBA 12/2012 - 04/2011
3	Immunoglobulins (Immunoglobulin)IBA 06/2012 - 12/2006
3	MHC class II transactivator proteinIBA 07/2009 - 05/2005
2	ponesimodIBA 01/2022 - 11/2014
2	SmokeIBA 01/2022 - 07/2014
2	Prostate-Specific Antigen (Semenogelase)IBA 04/2021 - 05/2012
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021 - 08/2010
2	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2021
2	Biological ProductsIBA 01/2021 - 01/2019
2	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2021 - 01/2021
2	InterferonsIBA 11/2020 - 10/2020
2	Dimethyl FumarateIBA 10/2020 - 12/2019
2	Glatiramer Acetate (Copaxone)FDA Link 01/2020 - 01/2015
2	Interferon-betaIBA 01/2020 - 11/2014
2	Retinaldehyde (Retinal)IBA 11/2019 - 01/2017
2	Coffee FDA Link 01/2019 - 01/2017
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2019 - 10/2014
2	Nicotine FDA Link 01/2019 - 01/2017
2	Carrier Proteins (Binding Protein)IBA 01/2019 - 01/2017
2	Integrin alpha4beta1 (VLA-4)IBA 01/2019 - 04/2014
2	AnoctaminsIBA 01/2019 - 02/2016
2	CXC ChemokinesIBA 01/2019 - 01/2013
2	Tumor Necrosis Factor Ligand Superfamily Member 14IBA 11/2017 - 08/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2017 - 11/2016
2	Protein Isoforms (Isoforms)IBA 11/2017 - 12/2012
2	EnzymesIBA 11/2017 - 01/2017
2	NADPH Oxidases (NAD(P)H oxidase)IBA 11/2017 - 04/2009
2	pandemrixIBA 10/2017 - 05/2014

Therapy/Procedure

13	Therapeutics 04/2022 - 04/2011